You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

disseminated neuroblastoma

Showing 1 - 25 of 876
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

Active, not recruiting
Has Results
  • Disseminated Neuroblastoma
  • +5 more
  • Birmingham, Alabama
  • +22 more
Mar 3, 2022

Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (drug,

Active, not recruiting
Has Results
  • Disseminated Neuroblastoma
  • +4 more
  • Birmingham, Alabama
  • +120 more
Mar 3, 2022

Neuroblastoma Trial in New York (beta-glucan, mAb 3F8, immunohistochemistry staining method)

Completed
  • Neuroblastoma
  • beta-glucan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 4, 2022

Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

Completed
Has Results
  • Neuroblastoma
  • anti-GD2 murine IgG3 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 21, 2022

Disseminated Neuroblastoma, Recurrent Neuroblastoma Trial in Canada, United States (ABT-751, quality-of-life assessment)

Completed
Has Results
  • Disseminated Neuroblastoma
  • Recurrent Neuroblastoma
  • Birmingham, Alabama
  • +11 more
Jul 2, 2019

Neuroblastoma Trial in Pilar, Buenos Aires (Racotumomab)

Active, not recruiting
  • Neuroblastoma
  • Pilar, Buenos Aires, Argentina
  • +1 more
Sep 30, 2021

Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide

Active, not recruiting
Has Results
  • Localized Resectable Neuroblastoma
  • +5 more
  • Aldesleukin
  • +6 more
  • Birmingham, Alabama
  • +196 more
Dec 30, 2022

Disseminated Neuroblastoma, Recurrent Neuroblastoma Trial in Detroit, New York, Charlottesville (IL-2, GD2Bi-aATC, GM-CSF)

Unknown status
  • Disseminated Neuroblastoma
  • Recurrent Neuroblastoma
  • IL-2
  • +3 more
  • Detroit, Michigan
  • +2 more
Jan 25, 2019

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Neuroblastoma Trial in Worldwide (carboplatin, cyclophosphamide, doxorubicin HCl)

Completed
Has Results
  • Neuroblastoma
  • Birmingham, Alabama
  • +188 more
Jul 1, 2021

Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)

Completed
Has Results
  • Brain Tumor
  • +8 more
  • sodium thiosulfate
  • examination
  • Birmingham, Alabama
  • +75 more
Jul 1, 2021

High Risk Neuroblastoma Trial in United States (biological, other, drug)

Completed
Has Results
  • High Risk Neuroblastoma
  • Aldesleukin
  • +4 more
  • Loma Linda, California
  • +31 more
Jul 30, 2021

Neuroblastoma Trial (Naxitamab)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Sep 18, 2023

Neuroblastoma Patients

Not yet recruiting
  • Neuroblastoma
    • San Francisco, California
      Power Life Sciences
    Jun 15, 2023

    Neuroblastoma Trial (GD2 CAR T cells)

    Not yet recruiting
    • Neuroblastoma
    • GD2 CAR T cells
    • (no location specified)
    Aug 5, 2023

    Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

    Recruiting
    • Neuroblastoma
    • Ganglioneuroblastoma
    • monoclonal antibodies GD2
    • Moscow, Russian Federation
      Research Institute of Pediatric Hematology, Oncology and Immunol
    Oct 4, 2023

    Patients With Previously Diagnosed High-Risk Neuroblastoma

    Active, not recruiting
    • Recurrent Neuroblastoma
    • +5 more
    • Cytology Specimen Collection Procedure
    • +2 more
    • Birmingham, Alabama
    • +97 more
    Oct 28, 2022

    Neuroblastoma Biology Study

    Recruiting
    • Neuroblastoma
      • Los Angeles, California
      • +13 more
      May 18, 2022

      Neuroblastoma Trial in Copenhagen (18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT))

      Recruiting
      • Neuroblastoma
      • 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)
      • Copenhagen, Denmark
        Rigshospitalet, Copenhagen University Hospital
      Apr 11, 2023

      Hemostatic Biomarkers in Disseminated Intravascular Coagulation

      Recruiting
      • Disseminated Intravascular Coagulation
      • no intervention
      • Ji'nan, Shandong, China
        Miao Xu
      Aug 12, 2023

      Refractory/Relapse Neuroblastoma, Pediatric Solid Tumors With Lung Metastases Trial in Fukuoka (Biological)

      Recruiting
      • Refractory/Relapse Neuroblastoma
      • Pediatric Solid Tumors With Lung Metastases
      • Biological
      • Fukuoka, Japan
        Kyushu University Hospital
      Nov 7, 2022

      Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)

      Recruiting
      • Neuroblastoma
      • +2 more
      • OPT-821 (QS-21)
      • oral β-glucan
      • Basking Ridge, New Jersey
      • +6 more
      Sep 21, 2023

      Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

      Recruiting
      • Neuroblastoma
      • Pediatric Solid Tumor
      • Tissue collection
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Oct 17, 2022

      Neuroblastoma Trial in Canada, United States (Eflornithine)

      Recruiting
      • Neuroblastoma
      • Little Rock, Arkansas
      • +22 more
      Jan 23, 2023

      Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Australia, Canada,

      Completed
      Has Results
      • Localized Resectable Neuroblastoma
      • +4 more
      • Clinical Observation
      • +5 more
      • Birmingham, Alabama
      • +103 more
      Jan 4, 2023